Abeona

Abeona Therapeutics is a clinical-stage biopharmaceutical company that focuses on developing gene and cell therapies for serious genetic diseases. They primarily make money through research grants, partnerships, and potential future sales of their therapies. Founded in 2013, Abeona has made significant strides in addressing conditions like recessive dystrophic epidermolysis bullosa and Sanfilippo syndrome. Notably, their proprietary AIM™ AAV vector platform is a key innovation in their therapeutic approach.

Recent Posts by Abeona

1-15 of 15